DJIA 17,616.97 20.62 0.12%
NASDAQ 4,987.66 29.19 0.59%
S&P 500 2,066.13 8.49 0.41%
market minute promo

Biogen Idec (NASDAQ: BIIB)

404.46 8.25 (2.08%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

BIIB $404.39 2.06%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $403.55
Previous Close $396.21
Daily Range $396.66 - $404.24
52-Week Range $290.85 - $480.18
Market Cap $95.1B
P/E Ratio 28.63
Dividend (Yield) $0.00 (0.0%)
Volume 1,039,474
Average Daily Volume 1,223,485
Current FY EPS $16.59




Drug Makers

Biogen Idec (BIIB) Description

The Company creates new standards of care in oncology, neurology, immunology and other specialty areas of unmet medical need and engaged in the development, manufacturing, and commercialization of novel therapies. Website:

News & Commentary Rss Feed

3 Stocks to Buy if Biotech Crashes

One Fool highlights three biotech stocks worth considering as biotech stocks drop.

3 Drugs Stocks Driving The Industry Higher

Biotech Investors Should Read Bibliographies Of Chief Scientific Officers

Biogen/Sobi's Hemophilia B Drug Alprolix under EU Review - Analyst Blog

Biogen/Sobi's Hemophilia B Drug Alprolix under EU Review - Analyst Blog

VUG, ORCL, V, BIIB: Large Outflows Detected at ETF

What Is Carl Icahn's Net Worth?

A look at the billionaire activist investor and hedge-fund manager, including some cautionary tales.

Lilly's Alzheimer's Game

Transition Therapeutics Tanks on Alzheimer's Disease Data - Analyst Blog

Short Sellers Get More Selective on Big Biotech

Here's Why Biogen Is Looking Good After A 14% Pullback

See More BIIB News...

BIIB's Top Competitors

BIIB $404.46 (2.08%)
Current stock: BIIB
AMGN $153.69 (1.38%)
Current stock: AMGN
GILD $117.31 (1.61%)
Current stock: GILD
$0.00 (0.00%)
Current stock: